QZW

Over-The-Counter Device To Assess Risk Of Sleep Apnea

产品代码
QZW
器械名称
Over-The-Counter Device To Assess Risk Of Sleep Apnea
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 868.2378
FDA 专业组
Anesthesiology
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
3 件
其中 Summary 已存档
2 份,可直接下载
FDA 历史累计 510(k)
3 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

An over-the-counter device to assess risk of sleep apnea is intended to provide a notification of the risk of sleep apnea in users who have not been previously diagnosed with sleep apnea. This device uses software algorithms to analyze input sensor signals and provide a risk assessment for sleep apnea. It is not intended to provide a standalone diagnosis, replace traditional methods of diagnosis (e.g., polysomnography), assist clinicians in diagnosing sleep disorders, or be used as an apnea monitor.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(3 件)

数据窗口为最近三年。最新一件:2026-07-20。

510(k) 号批准日期申请人器械名称摘要
K2610112026-07-20Samsung Electronics Co., Ltd.Sleep Apnea Feature (v2.0)PDF
K2409292024-09-13Apple, Inc.Sleep Apnea Notification Feature (SANF)PDF
DEN2300412024-02-06Samsung Electronics Co., Ltd.Sleep Apnea Feature

其中 2 件的 Summary 已存档在本站,点 PDF 直接下载;其余给 FDA 官方链接。

FDA 官方分类页: QZW
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。